A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to 17 Years With Ulcerative Colitis
Condition:   Ulcerative Colitis (UC) Interventions:   Drug: Mesalamine;   Drug: Placebo Sponsor:   AbbVie Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 7, 2022 Category: Research Source Type: clinical trials

HCQ for Non Europeans With Mild to Severe UC
Condition:   Ulcerative Colitis (Disorder) Interventions:   Drug: Hydroxychloroquine;   Drug: Mesalamine Sponsors:   Icahn School of Medicine at Mount Sinai;   Crohn's and Colitis Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 12, 2021 Category: Research Source Type: clinical trials